We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
276
Eaton
ETN
$161B
$7.1M 0.1%
19,900
-85
-0.4% -$26.2K
ABBV icon
277
AbbVie
ABBV
$443B
$7.03M 0.1%
37,862
DNLI icon
278
Denali Therapeutics
DNLI
$3.65B
$7M 0.1%
500,559
+219,420
+78% +$3.09M
DECK icon
279
Deckers Outdoor
DECK
$13.2B
$6.98M 0.1%
+67,761
New +$7.5M
LMAT icon
280
LeMaitre Vascular
LMAT
$2.32B
$6.88M 0.1%
82,795
+6,335
+8% +$529K
SBUX icon
281
Starbucks
SBUX
$120B
$6.82M 0.1%
74,453
-17,672
-19% -$1.53M
LOAR icon
282
Loar Holdings
LOAR
$6.41B
$6.66M 0.09%
+77,261
New +$6.69M
PTGX icon
283
Protagonist Therapeutics
PTGX
$8.79B
$6.64M 0.09%
+120,159
New +$5.77M
ADI icon
284
Analog Devices
ADI
$179B
$6.58M 0.09%
+27,658
New +$5.76M
BBCA icon
285
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
$6.56M 0.09%
81,304
-2,369
-3% -$179K
GPK icon
286
Graphic Packaging
GPK
$3.17B
$6.52M 0.09%
309,365
+12,042
+4% +$278K
CIVI
287
DELISTED
Civitas Resources
CIVI
$6.41M 0.09%
232,960
-103,016
-31% -$2.98M
J icon
288
Jacobs Solutions
J
$15.9B
$6.4M 0.09%
48,702
-65,282
-57% -$8.05M
IBM icon
289
IBM
IBM
$211B
$6.39M 0.09%
21,680
-2,057
-9% -$530K
ALGT icon
290
Allegiant Air
ALGT
$2.64B
$6.28M 0.09%
114,207
-1,160
-1% -$59.8K
IWM icon
291
iShares Russell 2000 ETF
IWM
$79.8B
$5.93M 0.08%
27,503
-13,700
-33% -$2.76M
IDCC icon
292
InterDigital
IDCC
$7.87B
$5.93M 0.08%
26,451
-1,817
-6% -$385K
GXO icon
293
GXO Logistics
GXO
$5.77B
$5.89M 0.08%
+121,042
New +$4.82M
RVLV icon
294
Revolve Group
RVLV
$1.8B
$5.89M 0.08%
293,725
+49,618
+20% +$1M
PCVX icon
295
Vaxcyte
PCVX
$7.81B
$5.86M 0.08%
180,239
+30,477
+20% +$999K
VCEL icon
296
Vericel Corp
VCEL
$2.35B
$5.75M 0.08%
135,095
+60,185
+80% +$2.5M
AJG icon
297
Arthur J. Gallagher & Co
AJG
$64.1B
$5.73M 0.08%
17,895
-2,815
-14% -$928K
RRX icon
298
Regal Rexnord
RRX
$13.7B
$5.71M 0.08%
39,396
+1,171
+3% +$147K
COO icon
299
Cooper Companies
COO
$14.1B
$5.7M 0.08%
80,038
-3,273
-4% -$251K
NBIX icon
300
Neurocrine Biosciences
NBIX
$16.8B
$5.67M 0.08%
45,091
-8,012
-15% -$919K

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.